LLGL2 Increases Ca2+ Influx and Exerts Oncogenic Activities via PI3K/AKT Signaling Pathway in Hepatocellular Carcinoma

被引:10
|
作者
Leng, Shusheng [1 ,2 ,3 ]
Xie, Fei [4 ]
Liu, Junyi [5 ]
Shen, Junyi [1 ,2 ]
Quan, Guangqian [1 ,2 ]
Wen, Tianfu [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Liver Transplantat Ctr, Chengdu, Peoples R China
[3] Chengdu Univ, Clin Med Coll, Affiliated Hosp, Gen Surg Dept, Chengdu, Peoples R China
[4] First Peoples Hosp Neijiang City, Dept Hepatobiliary Pancreat & Splen Surg, Neijiang, Peoples R China
[5] Chengdu Univ, Clin Med Coll, Affiliated Hosp, Cent Lab, Chengdu, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
LLGL2; Hepatocellular Carcinoma; PI3K; AKT signaling; Calcium influx; Progression; HUMAN HOMOLOG; DROSOPHILA; LGL; HUGL-1; POLARITY; EXPRESSION; MORPHOGENESIS; DIVISION; CLONING; GROWTH;
D O I
10.3389/fonc.2021.683629
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Lethal giant larvae (Lgl), scaffolding proteins, regulate the epithelial cell apicobasal polarity in Drosophila. They play important roles in asymmetric cell division, cell migration, and progenitor cells self-renewal as tumor suppressors. One of Lgl mammalian homologues proteins, LLGL2 overexpression has been reported in ER+ breast cancer and promotes tumor proliferation through regulating leucine uptake. Nonetheless, the role of LLGL2 in hepatocellular carcinoma (HCC) is still unknown. Methods TCGA dataset mining, qRT-PCR, Western blot along with immunohistochemistry assays were employed to explore LLGL2 expression in human HCC samples and cell lines. Moreover, the clinical value of LLGL2 was investigated in 156 HCC patients. Furthermore, the role as well as the molecular mechanism of LLGL2 in the progression of HCC was explored through a series of in vitro and in vivo experiments. Results LLGL2 was up-regulated in HCC tissues, which was related with certain clinicopathological features including tumor number, vascular invasion as well as advanced stage. High expression of LLGL2 predicted poor prognosis after hepatectomy. LLGL2 promoted HCC cells proliferation, migration and invasion through PI3K/ATK signaling by promoting calcium ion influx. Conclusion Our study identified that LLGL2 is a tumor promoter in HCC for the first time, which could potentially be utilized as a new biomarker and a therapeutic target for HCC.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] MicroRNA-126 accelerates IgE-mediated mast cell degranulation associated with the PI3K/Akt signaling pathway by promoting Ca2+ influx
    Bao, Yuan
    Wang, Song
    Gao, Yang
    Zhang, Wen
    Jin, Haitao
    Yang, Yang
    Li, Jiangyu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (03) : 2763 - 2769
  • [42] NEDD4 promotes cell growth and migration via PTEN/PI3K/AKT signaling in hepatocellular carcinoma
    Huang, Zhi-Jun
    Zhu, Jun-Jun
    Yang, Xiao-Yu
    Biskup, Ewelina
    ONCOLOGY LETTERS, 2017, 14 (03) : 2649 - 2656
  • [43] RUNX2 Plays An Oncogenic Role in Esophageal Carcinoma by Activating the PI3K/AKT and ERK Signaling Pathways
    Lu, Huibin
    Jiang, Tian
    Ren, Kewei
    Li, Zongming
    Ren, Jianzhuang
    Wu, Gang
    Han, Xinwei
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 49 (01) : 217 - 225
  • [44] Knockdown of hsa_circ_0001964 inhibits hepatocellular carcinoma cell proliferation by inactivating PI3K/AKT signaling pathway
    Li, Liao
    Miao, Changfeng
    Peng, Shayong
    Jiang, Yu
    Lu, Xinchun
    MOLECULAR & CELLULAR TOXICOLOGY, 2022, 18 (02) : 185 - 191
  • [45] Tenacissoside H Induces Autophagy and Radiosensitivity of Hepatocellular Carcinoma Cells by PI3K/Akt/mTOR Signaling Pathway
    Lin, Jiatian
    Ruan, Jiyin
    Zhu, Hao
    Chen, Zaizhong
    Chen, Junhui
    Yu, Hongjian
    DOSE-RESPONSE, 2021, 19 (02):
  • [46] Downregulation of MTHFD2 Inhibits Proliferation and Enhances Chemosensitivity in Hepatocellular Carcinoma via PI3K/AKT Pathway
    Wang, Jie
    Yu, Ze
    Jiang, Yixiao
    Le, Ting
    Wu, Yixin
    Li, Ziqi
    Zhang, Guoqiang
    Wu, Feiyue
    Ma, Haijie
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (01):
  • [47] TFAP4 Promotes Hepatocellular Carcinoma Invasion and Metastasis via Activating the PI3K/AKT Signaling Pathway
    Huang, Tao
    Chen, Qi-Feng
    Chang, Bo-Yang
    Shen, Lu-Jun
    Li, Wang
    Wu, Pei-Hong
    Fan, Wei-Jun
    DISEASE MARKERS, 2019, 2019
  • [48] Sema3d Restrained Hepatocellular Carcinoma Progression Through Inactivating Pi3k/Akt Signaling via Interaction With FLNA
    Li, Yiming
    Xu, Cong
    Sun, Bo
    Zhong, Fangjing
    Cao, Momo
    Yang, Lianyue
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [49] Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway
    Wang, Haiyong
    Zhang, Chenyue
    Xu, Litao
    Zang, Kun
    Ning, Zhouyu
    Jiang, Feng
    Chi, Huiying
    Zhu, Xiaoyan
    Meng, Zhiqiang
    ONCOTARGET, 2016, 7 (15) : 20193 - 20208
  • [50] Aberrant expression of PI3K/AKT signaling is involved in apoptosis resistance of hepatocellular carcinoma
    Wang, Zhuangqiang
    Cui, Xiaopeng
    Hao, Gaopeng
    He, Jiefeng
    OPEN LIFE SCIENCES, 2021, 16 (01): : 1037 - 1044